This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
1. AP Simopoulos (2006) Evolutionary aspects of diet, the omega-6/omega-3 ratio and genetic variation: nutritional implications for chronic diseases. Biomed Pharmacother 60, 502–507.
2. WS Harris (2006) The omega-6/omega-3 ratio and cardiovascular disease risk: uses and abuses. Curr Atheroscler Rep 8, 453–459.
3. PM Kris-Etherton , WS Harris & LJ Appel (2002) AHA Scientific Statement. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 106, 2747–2757.
5. M Plourde & S Cunnane (2007) Extremely limited synthesis of long chain polyunsaturates in adults: implications for their dietary essentiality and use as supplements. Appl Physiol Nutr Metab 32, 619–634.
7. CA Anderson & LJ Appel (2006) Dietary modification and CVD prevention: a matter of fat. JAMA 295, 693–695.
8. L Mosca , LJ Appel , EJ Benjamin (2004) Evidence-based guidelines for cardiovascular disease prevention in women. American Heart Association scientific statement. Arterioscler Thromb Vasc Biol 24, e29–e50.
10. MP Freeman , JR Hibbeln , KL Wisner (2006) Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry. J Clin Psychiatry 67, 1954–1967.
12. M Makrides (2008) Outcomes for mothers and their babies: do n-3 long-chain polyunsaturated fatty acids and seafoods make a difference? J Am Diet Assoc 108, 1622–1626.
14. SM Innis (2003) Perinatal biochemistry and physiology of long-chain polyunsaturated fatty acids. J Pediatr 143, 4 Suppl., 1s–8s.
15. SC Cunnane , V Francescutti , JT Brenna & MA Crawford (2000) Breast-fed infants achieve a higher rate of brain and whole body docosahexaenoate accumulation than formula-fed infants not consuming dietary docosahexaenoate. Lipids 35, 105–111.
16. SE Carlson (2009) Docosahexaenoic acid supplementation in pregnancy and lactation. Am J Clin Nutr 89, 678s–684s.
19. AP Simopoulos , A Leaf & N Salem Jr (2000) Workshop statement on the essentiality of and recommended dietary intakes for omega-6 and omega-3 fatty acids. Prostaglandins Leukot Essent Fatty Acids 63, 119–121.
21. E Dewailly , C Blanchet , S Gingras , S Lemieux & BJ Holub (2003) Fish consumption and blood lipids in three ethnic groups of Quebec (Canada). Lipids 38, 359–365.
34. American Heart Association Nutrition Committee, AH Lichtenstein , LJ Appel , M Brands (2006) Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee. Circulation 114, 82–96.
35. AP Simopoulos , A Leaf & N Salem Jr (1999) Essentiality of and recommended dietary intakes for omega-6 and omega-3 fatty acids. Ann Nutr Metab 43, 127–130.
38. F Van de Werf , D Ardissino , A Betriu (2003) Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the management of acute myocardial infarction of the European Society of Cardiology. Eur Heart J 24, 28–66.
40. D Mozaffarian & EB Rimm (2006) Fish intake, contaminants, and human health: evaluating the risks and the benefits. JAMA 296, 1885–1899.
41. H Iso , M Kobayashi , J Ishihara , S Sasaki , K Okada , Y Kita , Y Kokubo & S Tsugane (2006) Intake of fish and n-3 fatty acids and risk of coronary heart disease among Japanese. The Japan Public Health Center-Based (JPHC) Study Cohort I. Circulation 113, 195–202.
44. MT Clandinin , JE Chappell , S Leong , T Heim , PR Swyer & GW Chance (1980) Intrauterine fatty acid accretion rates in human brain: implications for fatty acid requirements. Early Hum Dev 4, 121–129.
45. M Martinez (1992) Tissue levels of polyunsaturated fatty acids during early human development. J Pediatr 120, s129–s138.
46. WS Harris & C Von Schacky (2004) The Omega-3 Index: a new risk factor for death from coronary heart disease? Prev Med 39, 212–220.
47. WS Harris , SA Sands , SL Windsor , HA Ali , TL Stevens , A Magalski , CB Porter & AM Borkon (2004) Omega-3 fatty acids in cardiac biopsies from heart transplantation patients. Correlation with erythrocytes and response to supplementation. Circulation 110, 1645–1649.
48. RC Kessler , RB Davis , DF Foster , MI Van Rompay , EE Walters , SA Wilkey , TJ Kaptchuk & DM Eisenberg (2001) Long-term trends in the use of complementary and alternative medical therapies in the United States. Ann Intern Med 135, 262–268.
50. TP Johnson , AL Holbrook , Y Ik Cho & RM Bossarte (2006) Nonresponse error in injury-risk surveys. Am J Prev Med 31, 427–436.
51. S Keeter , C Miller , A Kohut , RM Groves & S Presser (2000) Consequences of reducing nonresponse in a national telephone survey. Public Opin Q 64, 125–148.
52. R Curtin , S Presser & E Singer (2000) The effects of response rate changes on the index of consumer sentiment. Public Opin Q 64, 413–428.
53. JP Hox & ED De Leeuw (1994) A comparison of nonresponse in mail, telephone, and face-to-face surveys: applying multilevel modeling to meta-analysis. Qual Quant 28, 329–344.
54. G Burdge (2004) Alpha-linolenic acid metabolism in men and women: nutritional and biological implications. Curr Opin Clin Nutr Metab Care 7, 137–144.
56. C Blanchet , M Lucas , P Julien , R Morin , S Gingras & E Dewailly (2005) Fatty acid composition of wild and farmed Atlantic salmon (Salmo salar) and rainbow trout (Oncorhynchus mykiss). Lipids 40, 529–531.
58. M Lamotte , L Annemans , P Kawalec & Y Zoellner (2006) A multi-country health economic evaluation of highly concentrated N-3 polyunsaturated fatty acids in secondary prevention after myocardial infarction. Pharmacoeconomics 24, 783–795.